UB Paderborn / Katalog / Suche / in CDI

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

Rheumatology (Oxford, England), 2019-02, Vol.58 (2), p.e3-e42

2019

Volltextzugriff (PDF)

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summary

Rheumatology (Oxford, England), 2019-02, Vol.58 (2), p.220-226

2019

Volltextzugriff (PDF)

Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?

BMC musculoskeletal disorders, 2020-04, Vol.21 (1), p.209-209, Article 209

2020

Volltextzugriff (PDF)

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

Rheumatology (Oxford, England), 2019-02, Vol.58 (2), p.372-372

2019

Volltextzugriff (PDF)

Parent-Offspring Associations in Body Composition: Findings From the Southampton Women's Survey Prospective Cohort Study

The journal of clinical endocrinology and metabolism, 2023-08, Vol.108 (9), p.e726-e733

2023

Volltextzugriff (PDF)

Does Combined Clinical and Ultrasound Assessment Allow Selection of Individuals With Rheumatoid Arthritis for Sustained Reduction of Anti–Tumor Necrosis Factor Therapy?

Arthritis care & research (2010), 2015-06, Vol.67 (6), p.746-753

2015

Volltextzugriff (PDF)

Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis

Clinical and experimental rheumatology, 2018-01, Vol.36 (1), p.171

2018

Volltextzugriff (PDF)

Placental Size Is Associated Differentially With Postnatal Bone Size and Density

Journal of bone and mineral research, 2016-10, Vol.31 (10), p.1855-1864

2016

Volltextzugriff (PDF)

Are there dangers in biologic dose reduction strategies?

Autoimmunity reviews, 2016-07, Vol.15 (7), p.742-746

2016

Volltextzugriff (PDF)

I38. BIOLOGICS AND SAFETY ISSUES GUIDELINE

Rheumatology (Oxford, England), 2017-04, Vol.56 (suppl_2)

Holroyd, Christopher R.

2017

Volltextzugriff (PDF)

New targeted treatments for autoimmune diseases and complications in acute medicine

Medicine (Abingdon. 1995, UK ed.), 2021-03, Vol.49 (3), p.136-139

2021

Volltextzugriff (PDF)

Vitamin D and the postmenopausal population

Menopause international, 2011-09, Vol.17 (3), p.102

2011

Volltextzugriff (PDF)

OA02 Real-world experience of dose tapering TNF inhibitors in rheumatoid arthritis: Long-term results

Rheumatology (Oxford, England), 2023-04, Vol.62 (Supplement_2)

2023

Volltextzugriff (PDF)

209Vaccinations and Biologic Therapy: Patient Perspective and Audit Findings from the Southampton Biologics Service

Rheumatology (Oxford, England), 2016-04, Vol.55 (suppl_1), p.i146-i147

2016

Volltextzugriff (PDF)

O18. DXA Measures of Bone Mass in Mother, Father and Offspring: Results from the Southampton Women’s Survey

Rheumatology (Oxford, England), 2014-04, Vol.53 (suppl_1), p.i33-i33

2014

Volltextzugriff (PDF)

99. Identifying Characteristics of RA Patients Able to Reduce Anti-TNF Using a Real-Life Strategy Combining Clinical and Ultrasound Assessment

Rheumatology (Oxford, England), 2014-04, Vol.53 (suppl_1), p.i94-i94

2014

Volltextzugriff (PDF)

Population genomic and evolutionary modelling analyses reveal a single major QTL for ivermectin drug resistance in the pathogenic nematode, Haemonchus contortus

BMC genomics, 2019-03, Vol.20 (1), p.218-19, Article 218

2019

Volltextzugriff (PDF)

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Nature medicine, 2022-06, Vol.28 (6), p.1256-1268

2022

Volltextzugriff (PDF)

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Frontiers in genetics, 2021-07, Vol.12, p.707836-707836

2021

Volltextzugriff (PDF)

Population genomic evidence that human and animal infections in Africa come from the same populations of Dracunculus medinensis

PLoS neglected tropical diseases, 2020-11, Vol.14 (11), p.e0008623-e0008623

2020

Volltextzugriff (PDF)

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

Nature communications, 2017-12, Vol.8 (1), p.1892-1892, Article 1892

2017

Volltextzugriff (PDF)

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

Nature communications, 2018-09, Vol.9 (1), p.3707-10, Article 3707

2018

Volltextzugriff (PDF)

Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

Nature communications, 2018-04, Vol.9 (1), p.1340-9, Article 1340

2018

Volltextzugriff (PDF)

Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study

Inflammatory bowel diseases, 2023-10, Vol.29 (10), p.1536-1545

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summary

Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

Parent-Offspring Associations in Body Composition: Findings From the Southampton Women's Survey Prospective Cohort Study

Does Combined Clinical and Ultrasound Assessment Allow Selection of Individuals With Rheumatoid Arthritis for Sustained Reduction of Anti–Tumor Necrosis Factor Therapy?

Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis

Placental Size Is Associated Differentially With Postnatal Bone Size and Density

Are there dangers in biologic dose reduction strategies?

I38. BIOLOGICS AND SAFETY ISSUES GUIDELINE

New targeted treatments for autoimmune diseases and complications in acute medicine

Vitamin D and the postmenopausal population

OA02 Real-world experience of dose tapering TNF inhibitors in rheumatoid arthritis: Long-term results

209Vaccinations and Biologic Therapy: Patient Perspective and Audit Findings from the Southampton Biologics Service

O18. DXA Measures of Bone Mass in Mother, Father and Offspring: Results from the Southampton Women’s Survey

99. Identifying Characteristics of RA Patients Able to Reduce Anti-TNF Using a Real-Life Strategy Combining Clinical and Ultrasound Assessment

Population genomic and evolutionary modelling analyses reveal a single major QTL for ivermectin drug resistance in the pathogenic nematode, Haemonchus contortus

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Population genomic evidence that human and animal infections in Africa come from the same populations of Dracunculus medinensis

The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study

Suchergebnisse filtern